摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

quebrachamine | 14430-17-2

中文名称
——
中文别名
——
英文名称
quebrachamine
英文别名
(15S)-15-ethyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraene
quebrachamine化学式
CAS
14430-17-2
化学式
C19H26N2
mdl
——
分子量
282.429
InChiKey
FDNDLNFGITWTOZ-IBGZPJMESA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.3
  • 重原子数:
    21
  • 可旋转键数:
    1
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.58
  • 拓扑面积:
    19
  • 氢给体数:
    1
  • 氢受体数:
    1

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    NODE, MANABU;NAGASAWA, HIDEKO;FUJI, KAORU, J. AMER. CHEM. SOC., 109,(1987) N 25, 7901-7903
    摘要:
    DOI:
  • 作为产物:
    描述:
    (+)-(3S,5S)-3-allyl-3-ethyl-5-trityloxymethyltetrahydrofuran-2-one 在 盐酸氢氧化钾sodium periodate 、 lithium aluminium tetrahydride 、 5A molecular sieve 、 sodiumsilica gel溶剂黄146甲基磺酰氯 作用下, 以 四氢呋喃 为溶剂, 生成 quebrachamine
    参考文献:
    名称:
    使用单个手性合成子同时生成奎巴拉赫明的(+)-和(-)-对映异构体的对映选择性途径
    摘要:
    使用从L-谷氨酸或D-甘露糖醇中获得的单一手性内酯已经建立了对蛇床子型吲哚碱类(quebrachamine)的(+)-(-)和(-)-对映体的对映选择性途径。
    DOI:
    10.1039/c39810001153
点击查看最新优质反应信息

文献信息

  • Enantioselective synthesis of (+)-quebrachamine using L-glutamic acid as a chiral template
    作者:Seiichi Takano、Kenji Chiba、Masahiro Yonaga、Kunio Ogasawara
    DOI:10.1039/c39800000616
    日期:——
    (+)-Quebrachamine (1) has been synthesised enantioselectively using L-glutamic acid as a chiral template.
    使用L-谷氨酸作为手性模板,对映选择性地合成了(+)-瓜拉巴明(1)。
  • Highly Enantioselective Intermolecular Cu(I)-Catalyzed Cyclopropanation of Cyclic Enol Ethers. Asymmetric Total Synthesis of (+)-Quebrachamine
    作者:Oliver Temme、Shabbir-Ali Taj、Pher G. Andersson
    DOI:10.1021/jo9807417
    日期:1998.8.1
    structures 34c-h, the reaction was used as a key step in the asymmetric synthesis of (+)-quebrachamine 7, an indole alkaloid of the Aspidosperma family. After acid-induced ring opening of bicyclic compound 34f to lactone 40 followed by LiAlH(4) reduction to the masked aldehyde 41, a reaction with tryptamine gave intermediate 42. This alcohol was efficiently converted into the indole alkaloid (+)-quebrachamine
    合成了一组衍生自在烯烃体系上具有不同取代方式的2,3-二氢呋喃35和3,4-二氢吡喃8的环状烯醇醚。发现具有Cu(I)OTf的Evans配体5是环状烯醇醚14、19、28-31和33与重氮乙酸乙酯6的环丙烷化反应的有效催化剂,其非对映选择性高达exo / endo = 95:5几乎所有情况下对映选择性都高于95%。由于选择性地建立了一个四级碳中心,并且在形成双环结构34c-h中具有良好的收率,该反应被用作非对称合成(+)-quebrachamine 7(曲霉属的吲哚生物碱)的关键步骤。 。酸诱导双环化合物34f开环成内酯40,然后LiAlH(4)还原成掩蔽的醛41后,与色胺的反应得到中间体42。从手性合成子34f开始,将该醇有效地转化为吲哚生物碱(+)-quebrachamine 7,总产率为37%。此外,它揭示了环丙烷化产物34f的四元中心的绝对构型为S。
  • Enantiospecific total synthesis of indole alkaloids (+)-eburnamonine, (−)-aspidospermidine and (−)-quebrachamine
    作者:John Eugene Nidhiry、Kavirayani R. Prasad
    DOI:10.1016/j.tet.2013.04.097
    日期:2013.7
    An enantiospecific total synthesis of indole alkaloids eburnamonine, aspidospermidine and quebrachamine is described from lactic acid. Synthesis of all three alkaloids is accomplished from a single chiral building block. Johnson–Claisen rearrangement of a chiral allyl alcohol is the main feature for the installation of the required quaternary centre.
    从乳酸描述了对映体的吲哚生物碱氨丁环胺碱,aspspersmidine和quebrachamine的全合成。所有三个生物碱的合成是从一个手性结构单元完成的。Johnson-Claisen手性烯丙醇的重排是安装所需四元中心的主要特征。
  • CATALYSTS FOR METATHESIS REACTIONS INCLUDING ENANTIOSELECTIVE OLEFIN METATHESIS, AND RELATED METHODS
    申请人:Malcolmson Steven J.
    公开号:US20110065915A1
    公开(公告)日:2011-03-17
    The present invention provides compositions comprising metal complexes, and related methods. In some embodiments, metal complexes of the invention may be useful as catalysts for chemical reactions, including metathesis reactions, wherein the catalysts exhibit enhanced activity and stereoselectivity. In some embodiments, the invention may advantageously provide metal complexes comprising a stereogenic metal atom. Such metal complexes may be useful in enantioselective catalysis.
    本发明提供了包括金属配合物的组合物以及相关方法。在某些实施例中,本发明的金属配合物可能作为化学反应的催化剂而有用,包括交换反应,其中催化剂表现出增强的活性和立体选择性。在某些实施例中,本发明可能有利地提供包括具有立体异性金属原子的金属配合物。这种金属配合物可能在对映选择性催化中有用。
  • Diastereocontrolled synthesis of an enantiopure 4,4-disubstituted cyclohex-2-en-ol: a new route to (+)-quebrachamine
    作者:Takashi Fujimura、Hiromi Nakashima、Hideki Sakagami、Takahiko Taniguchi、Kunio Ogasawara
    DOI:10.1016/s0040-4039(01)02075-5
    日期:2002.1
    A diastereoselective route to an enantiopure 4,4-disubstituted cyclohex-2-en-1-ol has been developed using the synthetic equivalent of chiral 4-hydroxycyclohex-2-en-1-one. Its stereochemistry has been determined by its transformation into the Aspidosperma indole alkaloid (+)-quebrachamine.
    使用手性4-羟基环己基-2-en-1-one的合成等价物,开发了对映体纯的对映体4,4-二取代的环己基-2-en-1-ol的非对映选择性路线。它的立体化学已通过其转化为曲霉精吲哚生物碱(+)- quebrachamine来确定。
查看更多

同类化合物

(1aR,13S,13aS)-13-乙基-1a,4,5,10,11,12,13,13a-八氢-2H-3,13-甲桥环氧乙烷并[9,10]氮杂环十一碳五烯并[5,4-b]吲哚 (-)-dehydroquebrachamine (-)-N-methylquebrachamine tetradehydro-(+)-quebrachamine (+)-14,15-didehydroquebrachamine quebrachamine 5,6,11,12-tetrahydro-4H,13aH-3a,13-propanofuro[3',2':8,9]azonino[5,4-b]indol-2(3H)-one oxoquebrachamine (+)-N-methylquebrachamine (+/-)-vincadine Vincaminoreine vincadine quebrachamine (+/-)-epivincadine 14,15,16,17-Dehydroquebrachamin (15S)-15-ethyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,13,16-hexaene (15R)-15-ethyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,13,16-hexaene 15-Ethyl-11-aza-1-azoniapentacyclo[13.3.1.01,13.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaene 15-ethyl-11-aza-1-azoniapentacyclo[13.3.1.01,13.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaene;magnesium(1+) monohydride;hydroxide 5,10-Dioxo-quebrachamin 15-Ethyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,13,16-hexaene methyl N-[(15-ethyl-2-oxo-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaen-13-ylidene)amino]carbamate 15-Ethyl-11,18-dimethyl-17-oxa-1,11-diazapentacyclo[13.4.1.04,12.05,10.016,18]icosa-4(12),5,7,9-tetraene 15-Ethyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraene-16,17-diol 15-Ethyl-11-methyl-17-oxa-1,11-diazapentacyclo[13.4.1.04,12.05,10.016,18]icosa-4(12),5,7,9-tetraen-13-ol (1aR,13S,13aS)-13-Ethyl-1a,4,5,10,11,12,13,13a-octahydro-10-methyl-2H-3,13-methanooxireno[9,10]azacycloundecino[5,4-b]indole 15-Ethyl-17-oxa-1,11-diazapentacyclo[13.4.1.04,12.05,10.016,18]icosa-4(12),5,7,9-tetraen-13-ol 15-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4,6,8-tetraen-19-ol 15-Ethyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-17-ol 17-Ethoxy-19-oxa-5,15-diazapentacyclo[13.6.1.01,18.04,12.06,11]docosa-4(12),6,8,10-tetraene Ervayunine 15-Ethyl-11-methyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraene-16,17-diol 15-Ethyl-17-oxa-1,11-diazapentacyclo[13.4.1.04,12.05,10.016,18]icosa-4(12),5,7,9-tetraen-2-ol 15-Ethyl-17-oxa-1,11-diazapentacyclo[13.4.1.04,12.05,10.016,18]icosa-4(12),5,7,9-tetraen-19-one Vincadin 15-Ethyl-13-hydroxy-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-19-one (±)-N-methylquebrachamine quebrachamine Methyl 17-ethyl-19-oxa-3,13-diazapentacyclo[15.2.1.02,10.04,9.013,18]icosa-2(10),4,6,8,15-pentaene-1-carboxylate 15-Ethyl-11-(methoxymethyl)-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraene 9-Methoxy-quebrachamin dl-Vincaminorein Methyl 15-ethyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaene-13-carboxylate Methyl 15-ethyl-8-methoxy-11-methyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5(10),6,8-tetraene-13-carboxylate 13-Ethyl-9-methoxy-1a,4,5,10,11,12,13,13a-octahydro-2h-3,13-methanooxireno[9,10]azacycloundecino[5,4-b]indole 15-Ethyl-8-hydroxy-17-oxa-1,11-diazapentacyclo[13.4.1.04,12.05,10.016,18]icosa-4(12),5(10),6,8-tetraen-2-one